ATE205600T1 - Leukozytadhaesiontest - Google Patents

Leukozytadhaesiontest

Info

Publication number
ATE205600T1
ATE205600T1 AT94917743T AT94917743T ATE205600T1 AT E205600 T1 ATE205600 T1 AT E205600T1 AT 94917743 T AT94917743 T AT 94917743T AT 94917743 T AT94917743 T AT 94917743T AT E205600 T1 ATE205600 T1 AT E205600T1
Authority
AT
Austria
Prior art keywords
vascular tissue
adhesion test
leukocyte adhesion
monocyte
agents
Prior art date
Application number
AT94917743T
Other languages
English (en)
Inventor
Robin Poston
Original Assignee
Robin Poston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robin Poston filed Critical Robin Poston
Application granted granted Critical
Publication of ATE205600T1 publication Critical patent/ATE205600T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/803—Stabe free radicals, e.g. spin immunoassay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Ecology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT94917743T 1993-06-15 1994-06-14 Leukozytadhaesiontest ATE205600T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939312315A GB9312315D0 (en) 1993-06-15 1993-06-15 Leukocyte adhesion assay
PCT/GB1994/001279 WO1994029720A1 (en) 1993-06-15 1994-06-14 Leukocyte adhesion assay

Publications (1)

Publication Number Publication Date
ATE205600T1 true ATE205600T1 (de) 2001-09-15

Family

ID=10737184

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94917743T ATE205600T1 (de) 1993-06-15 1994-06-14 Leukozytadhaesiontest

Country Status (7)

Country Link
US (2) US5766838A (de)
EP (1) EP0704056B9 (de)
JP (1) JPH09500722A (de)
AT (1) ATE205600T1 (de)
DE (1) DE69428278T2 (de)
GB (1) GB9312315D0 (de)
WO (1) WO1994029720A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312315D0 (en) * 1993-06-15 1993-07-28 Poston Robin Leukocyte adhesion assay
WO1999052551A1 (en) * 1998-04-15 1999-10-21 King's College London Therapy of atherosclerosis
US7374906B2 (en) 2000-11-08 2008-05-20 Surface Logix, Inc. Biological assays using gradients formed in microfluidic systems
US6699665B1 (en) * 2000-11-08 2004-03-02 Surface Logix, Inc. Multiple array system for integrating bioarrays
US7326563B2 (en) * 2000-11-08 2008-02-05 Surface Logix, Inc. Device and method for monitoring leukocyte migration
GB2391600B (en) * 2001-04-27 2005-09-21 Fiberspar Corp Buoyancy control systems for tubes
US20050187468A1 (en) * 2001-11-29 2005-08-25 Atlas Glen M. Modified esophageal doppler monitor methods for measuring aortic dp/dt and pulse wave velocity
GB0128712D0 (en) * 2001-11-30 2002-01-23 Poston Robin Monocyte adhesion
US6679018B2 (en) * 2002-02-01 2004-01-20 Chem Link, Inc. Roofing system and method
US20030157586A1 (en) * 2002-02-21 2003-08-21 Martin Bonde Device and method for conducting cellular assays using multiple fluid flow
RU2701722C1 (ru) * 2018-11-19 2019-10-01 федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр имени В.А. Алмазова" Министерства здравоохранения Российской Федерации Способ оценки активационных возможностей гемоконтактных препаратов (в том числе сорбентов) по скорости адгезии клеток крови

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608068D0 (en) * 1986-04-02 1986-05-08 Cobbold S P Monoclonal antibodies
US4925678A (en) * 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
EP0279114B2 (de) * 1986-11-21 1995-08-23 Glaxo Group Limited Arzneimittel zur Behandlung oder Vorbeugung des Entzugssyndromes
DE3781263T2 (de) * 1986-12-15 1993-04-08 Inst Nat Sante Rech Med Peptid-derivate und deren verwendung in der therapie.
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
EP0278173B1 (de) * 1986-12-17 1993-11-03 Glaxo Group Limited Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen
US5108759A (en) * 1987-04-01 1992-04-28 Ranney David F Endothelial envelopment drug carriers
US4935234A (en) * 1987-06-11 1990-06-19 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
FR2619383B1 (fr) * 1987-08-12 1989-12-08 Inst Vaisseaux Sang Proteine a activite vasculaire, derivee des monocytes et ses analogues, procede pour son extraction et leurs utilisations en therapeutique et pour la preparation d'anticorps
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5217870A (en) * 1989-04-28 1993-06-08 Biogen, Inc. Monoclonal antibodies against CDX
US5166133A (en) * 1991-04-17 1992-11-24 Cetus Corporation Method for inhibing adhesion of white blood cells to endothelial cells
US5514555A (en) * 1993-03-12 1996-05-07 Center For Blood Research, Inc. Assays and therapeutic methods based on lymphocyte chemoattractants
GB9312315D0 (en) * 1993-06-15 1993-07-28 Poston Robin Leukocyte adhesion assay
US5503982A (en) * 1993-09-30 1996-04-02 Research Corporation Technologies, Inc. Detection of an acute myocardial infarction in a patient

Also Published As

Publication number Publication date
GB9312315D0 (en) 1993-07-28
DE69428278T2 (de) 2002-06-27
JPH09500722A (ja) 1997-01-21
EP0704056B1 (de) 2001-09-12
US5766838A (en) 1998-06-16
US6010845A (en) 2000-01-04
WO1994029720A1 (en) 1994-12-22
DE69428278D1 (de) 2001-10-18
EP0704056B9 (de) 2002-01-23
EP0704056A1 (de) 1996-04-03

Similar Documents

Publication Publication Date Title
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
BR9507140A (pt) Proteina dna vetor célula capaz de expressar uma proteina kit e processo de teste preparado de luciferase e uso de uma luciferase
ATE266723T1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
DE69738739D1 (de) Verfahren für das Entwerfen von kleinen Erythropoietin Mimetika
WO1993009437A3 (en) Nuclear matrix protein fluid assay
DE59508908D1 (de) Elektrochemischer Enzymbiosensor
ATE268385T1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
ATE205600T1 (de) Leukozytadhaesiontest
ES2133813T3 (es) Cadenas de lamininas: diagnostico y uso terapeutico.
DE69029398D1 (de) Hemmung von padgem-vermittelter zellbindung
WO2001016184A3 (en) Diagnostic assay for type 2 heparin-induced thrombocytopenia
CA2317816A1 (en) Peptide detection method
DE69826493D1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
CA2070647A1 (en) Use of an anticoagulant as a diagnostic agent
DE69714451D1 (de) Prionbindende proteine und deren verwendungen
DK0914043T3 (da) Implanterbare agarose-kollagen-korn, som indeholder celler, der dannet et diffunderbart produkt, og anvendelser heraf
DE69032329D1 (de) Für c.difficile spezifische oligonukleotide
ATE114817T1 (de) Immunologisches nachweisverfahren für herbizide.
ATE109983T1 (de) Gelkörper und verfahren für biologische sterilisierungssteuerung.
DE69636367D1 (de) T-pa polymorphismus und dessen verwendung zur risikodiagnose von thrombus assoziierten krankheiten
IT8819768A0 (it) Dispositivo perfezionato perl'esecuzione di esami microbiologici colturali.
NZ227184A (en) Method, slide and kit for assaying collagenolytic activity of mammalian biological fluids involving the use of collagen
NO972046L (no) Antistoff mot allogene og xenogene proteiner, deres bruk i diagnose og terapi samt fremgangsmåter for bestemmelse av slike
SE9203159D0 (sv) Partikel suspension
BR9814866A (pt) Uso de oligÈmeros de ácido poliamida nucléicopara produzir uma resposta biológica

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee